Medico Remedies Limited

MEDICO

INE630Y01024

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:49 2024-05-02 am EDT			5-day change	1st Jan Change
45.21 ^INR	-0.68%		-4.80%	-45.91%

Feb. 12	Medico Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
2023	Medico Remedies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	CI

Medico Remedies Limited Reports Earnings Results for the Half Year Ended September 30, 2020

November 12, 2020 at 06:26 am EST

Medico Remedies Limited announced earnings results for the half year ended September 30, 2020. For the half year, the company announced total revenue was INR 618.368 million compared to INR 436.108 million a year ago. Net income was INR 16.369 million compared to INR 8.016 million a year ago. Basic earnings per share from continuing operations was INR 3.95 compared to INR 1.93 a year ago.

Latest news about Medico Remedies Limited

Medico Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 12	CI
Medico Remedies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
Medico Remedies Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI
Medico Remedies to Foray into Ointment Manufacturing Business	23-05-14	MT
Medico Remedies Limited Completes Trial Production Round At the Newly Established State of the Art Ointment Manufacturing Plant At Palghar	23-05-13	CI
Medico Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-11	CI
Medico Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-10	CI
Medico Remedies Gets Board Nod for Stock Split	23-02-02	MT
Medico Remedies Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-12	CI
Medico Remedies Limited Announces Appointment of Deepesh Shah as an Additional Independent Director	22-04-22	CI
Medico Remedies Limited Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-12	CI
Medico Remedies : Gets Board Nod for Bonus Share Issue	21-10-07	MT
Medico Remedies Limited Reports Earnings Results for the Full Year Ended March 31, 2021	21-05-27	CI
834,900 Equity Shares of Medico Remedies Limited are subject to a Lock-Up Agreement Ending on 9-FEB-2021.	21-02-08	CI
Medico Remedies Limited Reports Earnings Results for the Half Year Ended September 30, 2020	20-11-12	CI
Medico Remedies Limited Reports Earnings Results for the Half Year Ended September 30, 2019	19-11-13	CI
Medico Remedies Limited Announces the Resignation of Shweta Harshit Mehta as Wholetime Director	19-10-23	CI
Medico Remedies Limited Announces Audited Financial Results for the Six Months and Year Ended March 31, 2019	19-05-25	CI
Medico Remedies Limited Appoints Dinesh Modi as Company Secretary	19-02-11	CI
2,215,100 Equity Shares of Medico Remedies Limited are subject to a Lock-Up Agreement Ending on 9-FEB-2019.	19-02-08	CI
Medico Remedies Pvt. Ltd. Reports Earnings Results for the Half Year Ended September 30, 2018	18-11-14	CI
Medico Remedies Limited Announces Resignation of Vipul Premshankar Dubey as Company Secretary with Effect from September 30, 2018	18-09-24	CI
Medico Remedies Limited Reports Audited Earnings Results for the Six Months and Financial Year Ended March 31, 2018	18-05-25	CI
Medico Remedies Limited Announces Shifting of Registered Office	18-04-30	CI
Medico Remedies Limited has completed an IPO in the amount of INR 109.92 million.	18-02-06	CI

Chart Medico Remedies Limited

Duration

Period

More charts

Company Profile

Medico Remedies Limited is an India-based pharmaceutical formulation manufacturing company. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. It has manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements. In addition, the Company also manufactures other drugs, such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Paediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others.

Sector

Pharmaceuticals

Calendar

2024-05-29 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
MEDICO REMEDIES LIMITED	-45.91%	45.25M
ELI LILLY AND COMPANY	+29.68%	699B
NOVO NORDISK A/S	+25.07%	571B
JOHNSON & JOHNSON	-4.35%	364B
MERCK & CO., INC.	+17.65%	326B
ABBVIE INC.	+3.77%	286B
ASTRAZENECA PLC	+14.68%	236B
NOVARTIS AG	+4.71%	198B
ROCHE HOLDING AG	-12.43%	194B
PFIZER, INC.	-3.79%	154B